IL17A and acute respiratory distress syndrome: I3C mitigated LPS-induced ARDS by decreasing various immune cells such as CD4+ RORγt +IL-17a+IL-22+ pathogenic Th17 cells but not CD4+RORγt +IL-17a+IL-22− homeostatic Th 17 cells in the lungs.